Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T14:58:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Version 3.4.2 (2026-02-03) adds Contacts/Locations and Study Status to the record history. The prior revision 3.4.0 (2025-10-06) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:42:36.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and a color-coded change legend; updated revision to v3.4.0 and removed the No FEAR Act Data and the v3.3.4 entry.
    Difference
    0.5%
    Check dated 2026-01-27T22:37:46.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Footer metadata changes: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T01:13:16.000Z thumbnail image
  7. Check
    106 days ago
    Change Detected
    Summary
    The page history shows a site release update: Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:25:42.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    Version label updated from v3.2.0 to v3.3.1 in the page footer; no visible changes to study data or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:42:59.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.